The UK Supreme Court has agreed to hear appeals concerning an investment treaty award that requires the Czech Republic to pay US$750 million to the founder of a collapsed blood plasma business.
To read more
Subscribe to Global Arbitration Review
Register for limited access
Register for free to receive GAR’s daily briefing and access to GAR 100.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Already have access? Login below